Role of Endothelin-1 Modulating Insulin-stimulated Blood Flow and Sympathetic Nervous System Activity in Obesity

NCT05518422 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped No participants enrolled

Conditions

Insulin Resistance
Autonomic Dysfunction
Obesity

Interventions

DRUG: Hyperinsulinemic, euglycemic infusion

Sponsor

University of Missouri-Columbia